We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




EMR-Based Tool Predicts Graft Failure After Kidney Transplant

By HospiMedica International staff writers
Posted on 12 Dec 2025

Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. More...

Although a successful transplant is expected to last about a decade, nearly one in four kidney grafts fail within five years, often without early warning signs. Clinicians currently lack reliable ways to identify which patients are most at risk of losing a transplanted kidney. A new study now shows that routinely collected kidney function data can be used to dynamically predict graft failure risk years before it happens.

Researchers at Johns Hopkins Medicine (Baltimore, MD, USA) have developed an electronic medical record (EMR)–based prediction model that continuously updates a patient’s risk of graft failure using changes in estimated glomerular filtration rate, a standard blood test that reflects how well a transplanted kidney is functioning. The approach allows risk to be recalculated every time new lab results become available.

The model was built using data from 1,114 deceased-donor kidney transplant recipients and validated across multiple large datasets, including national transplant registries and real-world hospital records. Investigators analyzed repeated kidney function measurements over time and linked these trajectories to graft failure, defined as a return to dialysis or the need for a second transplant within three years.

The results, published in the Clinical Journal of the American Society of Nephrology, showed that the model could effectively distinguish high-risk from low-risk patients. Predictive accuracy reached 0.70 just three months after transplant and improved to 0.90 by 30 months, demonstrating strong performance well before clinical failure occurred.

By identifying patients at elevated risk, the tool could support earlier interventions such as closer monitoring, adjustments to immunosuppressive therapy, and counseling about future transplant needs. At the same time, patients at low risk could safely transition back to routine nephrology care closer to home, freeing transplant center resources.

Researchers now plan to test the model in everyday clinical practice and expand it by incorporating additional health data, including clinical events and other laboratory markers. These efforts aim to further improve early detection of graft injury and long-term transplant outcomes.

“The results from this study can be readily implemented at transplant centers to streamline care of kidney transplant recipients by providing updated risk predictions as new data become available,” said Chirag Parikh, MD, PhD, the study’s senior author. “There could also be future downstream models developed to predict other infections and immunologic complications.”

Related Links:
Johns Hopkins Medicine


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.